Evidence map›Paper›PMID 24652793›Full record

ArticleJournal of the American Society of Nephrology : JASN2014

Translational profiles of medullary myofibroblasts during kidney fibrosis.

Ivica Grgic, A Michaela Krautzberger, Andreas Hofmeister, Matthew Lalli, Derek P DiRocco, Susanne V Fleig, Jing Liu, Jeremy S Duffield, Andrew P McMahon, Bruce Aronow and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. METTL3-mediated mActa biochimica et biophysica Sinica · 2025
    Article
  5. Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transition.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Role of Interleukin-6 Family Cytokines in Organ Fibrosis.Kidney diseases (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Ivica GrgicRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Internal Medicine and Nephrology, Philipps-University, Marburg, Germany;
A Michaela KrautzbergerDepartment of Stem Cell Biology and Regenerative Medicine, W.M. Keck School of Medicine of the University of Southern California, Los Angeles, California; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Los Angeles, California;
Andreas HofmeisterRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Internal Medicine and Nephrology, Philipps-University, Marburg, Germany;
Matthew LalliRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;
Derek P DiRoccoRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;
Susanne V FleigRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Nephrology, Hannover Medical School, Hannover, Germany;
Jing LiuDepartment of Stem Cell Biology and Regenerative Medicine, W.M. Keck School of Medicine of the University of Southern California, Los Angeles, California;
Jeremy S DuffieldDivision of Nephrology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington;
Andrew P McMahonDepartment of Stem Cell Biology and Regenerative Medicine, W.M. Keck School of Medicine of the University of Southern California, Los Angeles, California; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Los Angeles, California;
Bruce AronowUniversity of Cincinnati Department of Pediatrics, Cincinnati, Ohio; and.
Benjamin D HumphreysRenal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Kidney Group, Harvard Stem Cell Institute, Cambridge, Massachusetts bhumphreys@partners.org.
Brigham and Women's Hospital · USUniversity of Southern California · USHarvard University · USCalifornia Institute for Regenerative Medicine · USPhilipps University of Marburg · DEUniversity of Cincinnati · US

Funding

Pericyte-endothelial cross talk in vascular stability after kidney injuryR01DK093493 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2012 to 2016
$2.5M
Hedgehog Signaling in Kidney Homeostasis and RepairR01DK088923 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI HUMPHREYS, BENJAMIN D. · 2010 to 2014
$2.0M
Kidney pericytes in vascular regeneration after injuryRC1DK087389 · NIDDK · UNIVERSITY OF WASHINGTON · PI DUFFIELD, JEREMY S · 2009 to 2010
$989k
NIDDK NIH HHS DK088923NIDDK NIH HHS R01 DK088923NIDDK NIH HHS R01 DK093493NIDDK NIH HHS RC1 DK087389
6 · The paper itself

Abstract

Myofibroblasts secrete matrix during chronic injury, and their ablation ameliorates fibrosis. Development of new biomarkers and therapies for CKD will be aided by a detailed analysis of myofibroblast gene expression during the early stages of fibrosis. However, dissociating myofibroblasts from fibrotic kidney is challenging. We therefore adapted translational ribosome affinity purification (TRAP) to isolate and profile mRNA from myofibroblasts and their precursors during kidney fibrosis. We generated and characterized a transgenic mouse expressing an enhanced green fluorescent protein (eGFP)-tagged L10a ribosomal subunit protein under control of the collagen1α1 promoter. We developed a one-step procedure for isolation of polysomal RNA from collagen1α1-eGFPL10a mice subject to unilateral ureteral obstruction and analyzed and validated the resulting transcriptional profiles. Pathway analysis revealed strong gene signatures for cell proliferation, migration, and shape change. Numerous novel genes and candidate biomarkers were upregulated during fibrosis, specifically in myofibroblasts, and we validated these results by quantitative PCR, in situ, and Western blot analysis. This study provides a comprehensive analysis of early myofibroblast gene expression during kidney fibrosis and introduces a new technique for cell-specific polysomal mRNA isolation in kidney injury models that is suited for RNA-sequencing technologies.

Indexed as

AnimalsCollagen Type ICollagen Type I, alpha 1 ChainDisease Models, AnimalFibrosisGene Expression ProfilingGreen Fluorescent ProteinsKidneyMiceMice, Inbred C57BLMice, Inbred DBAMice, TransgenicMyofibroblastsOligonucleotide Array Sequence AnalysisRecombinant Fusion ProteinsRibosomal Protein L10Collagen Type ICollagen Type I, alpha 1 Chainenhanced green fluorescent proteinGreen Fluorescent ProteinsRecombinant Fusion ProteinsRibosomal ProteinsRNA, MessengerRpl10 protein, mouse

Identifiers

PMID24652793
PMCPMC4147988
OpenAlexW2135995266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.